SPRB SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

NEWForm 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 9, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 12, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 13, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 9, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 10, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2025

News

TYPE

HEADLINE

FILED AT

8-K

NEWSpruce Biosciences Reports Q3 2026 Financial Results and Provides Updates on TA-ERT BLA Submission and Corporate Restructuring

Nov 9, 2026

8-K

Spruce Biosciences Reports Q2 2026 Financial Results and Provides Updates on TA-ERT Program

Aug 12, 2026

8-K

Spruce Biosciences Appoints Adrian Quartel, M.D., as Chief Medical Officer

Jul 27, 2026

8-K

Spruce Biosciences, Inc. Announces Results of 2026 Annual Meeting of Stockholders

May 26, 2026

8-K

Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates

May 13, 2026

8-K

Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Apr 21, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Apr 21, 2026

424B5

PENDING FIXED PRICE OFFERING | Bank: Leerink Partners

Apr 20, 2026

424B5

March 2026 ATM | Offering amount: $75,000,000 | Bank: Jefferies LLC

Mar 9, 2026

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 735,325 | Share price: $68 | Warrants amount: 233,144

Dec 12, 2025

424B5

ATM | Offering amount: $21,000,000 | Amount sold to date: $0 | Float: 12,872,092

Feb 25, 2022

424B4

6,000,000 Shares

Oct 9, 2020

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 13, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 9, 2026

S-3

SHARE RESALE REGISTRATION

Oct 29, 2025

S-3

October 2025 SHELF | Offering amount: $300,000,000

Oct 29, 2025

Form D - Notice of Exempt Offering of Securities - Item 06b

Oct 16, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Apr 15, 2025

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A